Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 6,201 - 6,220 results of 105,667 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 0.96s Refine Results
  1. 6201
    Testis dysgenesis and decreased reproductive parameters after prenatal exposure to DEHP.

    Testis dysgenesis and decreased reproductive parameters after prenatal exposure to DEHP. by Ludwig Stenz (779897)

    Published 2017
    Save to List
    Saved in:
  2. 6202
    <i>shk-1</i> mutants display decreased glycogen storage.

    <i>shk-1</i> mutants display decreased glycogen storage. by Longjun Pu (20685717)

    Published 2025
    Save to List
    Saved in:
  3. 6203
    Characteristics of patients with AKI diagnosed using eKDIGO only by the decrease in sCr (deKDIGO) and no AKI.

    Characteristics of patients with AKI diagnosed using eKDIGO only by the decrease in sCr (deKDIGO) and no AKI. by Marina Wainstein (12437091)

    Published 2022
    Save to List
    Saved in:
  4. 6204
    Perturbation of binucleation decreases yolk protein expression and lipid transport to the germline.

    Perturbation of binucleation decreases yolk protein expression and lipid transport to the germline. by Lotte M. van Rijnberk (3716362)

    Published 2022
    Save to List
    Saved in:
  5. 6205
    Fluvastatin regulated AGE-induced cell cycle progression through an ERK5 activating pathway in VSMCs.

    Fluvastatin regulated AGE-induced cell cycle progression through an ERK5 activating pathway in VSMCs. by Ae-Rang Hwang (4040408)

    Published 2017
    Save to List
    Saved in:
  6. 6206
    Contains underlying data for Figs 1A, 1F, 1G, 1I, 1J, 2D, 2E, 2G, 2H, 2J, 2K, 2M, 2N, 3A, 3B, 3C, 3D, 3F, 4A, 4B, 4C, 4D, 4E, 5I, 6A, 6B, 6D, 6F, 7B, 7D, and 7F and S1A, S1B, S3A, S3C, S3D, S4B, S4D, S4F, S4G, S5A, S5B, S6B, S6D, S8A, S8B, S8D, S8E, and S8I Figs.

    Contains underlying data for Figs 1A, 1F, 1G, 1I, 1J, 2D, 2E, 2G, 2H, 2J, 2K, 2M, 2N, 3A, 3B, 3C, 3D, 3F, 4A, 4B, 4C, 4D, 4E, 5I, 6A, 6B, 6D, 6F, 7B, 7D, and 7F and S1A, S1B, S3A,... by Xiao Chen Shi (8611887)

    Published 2022
    Save to List
    Saved in:
  7. 6207
    Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson’s Disease - Fig 1

    Affective Disorders, Psychosis and Dementia in a Community Sample of Older Men with and without Parkinson’s Disease - Fig 1 by Osvaldo P. Almeida (95282)

    Published 2016
    Save to List
    Saved in:
  8. 6208
    The effect of Nrf2 siRNA on the ERK5 activation-mediated inhibition of AGE-induced VSMC proliferation.

    The effect of Nrf2 siRNA on the ERK5 activation-mediated inhibition of AGE-induced VSMC proliferation. by Ae-Rang Hwang (4040408)

    Published 2017
    Save to List
    Saved in:
  9. 6209
    Fluvastatin inhibited AGEs-induced cell proliferation through the ERK5-Nrf2 pathway in VSMCs.

    Fluvastatin inhibited AGEs-induced cell proliferation through the ERK5-Nrf2 pathway in VSMCs. by Ae-Rang Hwang (4040408)

    Published 2017
    Save to List
    Saved in:
  10. 6210
    Highest V1V2 IgG3 binding magnitude observed among ALVAC-HIV/AIDSVAX B/E only recipients.

    Highest V1V2 IgG3 binding magnitude observed among ALVAC-HIV/AIDSVAX B/E only recipients. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  11. 6211
    The effect of Nrf2 siRNA on the ERK5 activation-mediated inhibition of AGE-induced cell cycle progression.

    The effect of Nrf2 siRNA on the ERK5 activation-mediated inhibition of AGE-induced cell cycle progression. by Ae-Rang Hwang (4040408)

    Published 2017
    Save to List
    Saved in:
  12. 6212
    The making of a (dog) movie star (code).

    The making of a (dog) movie star (code). by Sarah Weir (11938602)

    Published 2022
    Save to List
    Saved in:
  13. 6213
    FX06 decreased capillary leak following LPS injection in rats.

    FX06 decreased capillary leak following LPS injection in rats. by Marion Gröger (264663)

    Published 2009
    Save to List
    Saved in:
  14. 6214
    Characterization of 5β-stanol (zoostanol) profiles of sediments from Buffalo Ford Lake in relation to the dung profiles of ungulates.

    Characterization of 5β-stanol (zoostanol) profiles of sediments from Buffalo Ford Lake in relation to the dung profiles of ungulates. by John A. F. Wendt (19976392)

    Published 2024
    Save to List
    Saved in:
  15. 6215
    Decreased Paneth cell number and the presence of granulomas differentiate HbTg from Tg animals at 10 days post Tg infection.

    Decreased Paneth cell number and the presence of granulomas differentiate HbTg from Tg animals at 10 days post Tg infection. by Edina K. Szabo (3160332)

    Published 2024
    Save to List
    Saved in:
  16. 6216
    GSK360A increased kidney EPO and brain VEGF mRNA after stroke.

    GSK360A increased kidney EPO and brain VEGF mRNA after stroke. by Jin Zhou (90734)

    Published 2017
    Save to List
    Saved in:
  17. 6217
    Antibody-dependent cellular phagocytosis (ADCP) is boosted by RV305 vaccination and is associated with IgG1 binding response.

    Antibody-dependent cellular phagocytosis (ADCP) is boosted by RV305 vaccination and is associated with IgG1 binding response. by LaTonya D. Williams (3140490)

    Published 2023
    Save to List
    Saved in:
  18. 6218
    Antisense RNA decreases AP33 gene expression and cytoadherence by -7

    Antisense RNA decreases AP33 gene expression and cytoadherence by -7 by V Mundodi (32881)

    Published 2011
    Save to List
    Saved in:
  19. 6219
    Antisense RNA decreases AP33 gene expression and cytoadherence by -0

    Antisense RNA decreases AP33 gene expression and cytoadherence by -0 by V Mundodi (32881)

    Published 2011
    Save to List
    Saved in:
  20. 6220
    Statins, manufacturers and dates that brand and generic formulations were first listed on the Nova Scotia Formulary.

    Statins, manufacturers and dates that brand and generic formulations were first listed on the Nova Scotia Formulary. by Laura V. Minard (349145)

    Published 2016
    Save to List
    Saved in:

Search Tools: